PEGGIE REINHARDT: Open Payments
NPI 1417367384 · ASHTABULA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,587 in 44 payments from 11 companies in 2025. Trend: 2023 $568 · 2024 $2,042 · 2025 $1,587
Food & beverage: $1,587
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $517 |
| Axsome Therapeutics, Inc. | 5 | $226 |
| ABBVIE INC. | 6 | $217 |
| Corcept Therapeutics | 5 | $204 |
| Lilly USA, LLC | 4 | $139 |
| Exact Sciences Corporation | 6 | $128 |
| Astellas Pharma US Inc | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Eisai Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: AIRSUPRA, Auvelity, Korlym, FARXIGA, QULIPTA, Cologuard Collection Kit, BREZTRI, ZEPBOUND.
Industry payments across OH — which companies pay providers there.
